The U.S. Food and Drug Administration (FDA) has received a small number of reports of adverse events that are believed to be associated with computed tomography (CT) imaging of some implantable and wearable electronic devices.

Just-released two-year follow-up data comparing coronary-artery bypass grafting (CABG) with combined CABG and mitral-valve repair in patients with moderate ischemic mitral regurgitation (IMR) found no significant differences in benefit.

The Centers for Medicare & Medicaid Services (CMS) announced its largest-ever initiative to transform and improve how primary care is delivered and paid for in America.